{"id":"W2044133019","doi":"10.3816/cbc.2010.n.011","title":"A Phase II Neoadjuvant Trial of Sequential Nanoparticle Albumin-Bound Paclitaxel Followed by 5-Fluorouracil/Epirubicin/Cyclophosphamide in Locally Advanced Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Epirubicin; Trastuzumab; Breast cancer; Paclitaxel; Internal medicine; Chemotherapy; Oncology; Cyclophosphamide; Clinical endpoint; Metastatic breast cancer; Febrile neutropenia; Anthracycline; Gastroenterology; Neutropenia; Cancer; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005690606,0.0005430031,0.0009807401,0.00006065749,0.0001863997,0.00002971109,0.0004634766,0.0004545941,0.0003830524],"category_scores_gemma":[0.0001749198,0.0004870475,0.0004626536,0.0003218856,0.0007460627,0.00003622687,0.0003562765,0.000514473,0.00001140492],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001266034,"about_ca_system_score_gemma":0.0007430692,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002462005,"about_ca_topic_score_gemma":0.004544225,"domain_scores_codex":[0.9960033,0.0001819606,0.001428838,0.001138553,0.0004216805,0.000825709],"domain_scores_gemma":[0.997843,0.0001240344,0.0005535049,0.0007691287,0.0003376467,0.0003726513],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.09031645,0.006719242,0.04479714,0.00004843485,0.0005864215,0.00002896954,0.0001389469,0.00005342754,0.6567864,0.00002800952,0.005475526,0.195021],"study_design_scores_gemma":[0.5151799,0.007364368,0.1492072,0.0005872385,0.0009467616,0.0001978435,0.0003308124,0.000196505,0.2949016,0.0002272647,0.02830012,0.002560449],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9885234,0.001909101,0.00003272482,0.003631252,0.002335775,0.0008688547,0.002557242,0.00003536906,0.0001063406],"genre_scores_gemma":[0.9955036,0.001314452,0.0001549287,0.0007445909,0.001137146,0.0006132282,0.0001225203,0.00007888635,0.0003306672],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4248634,"threshold_uncertainty_score":0.9997581,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01581447337146425,"score_gpt":0.3545481122868749,"score_spread":0.3387336389154106,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}